Postexposure prophylaxis, preexposure prophylaxis or universal test and treat: the strategic use of antiretroviral drugs to prevent HIV acquisition and transmission.

@article{Weber2010PostexposurePP,
  title={Postexposure prophylaxis, preexposure prophylaxis or universal test and treat: the strategic use of antiretroviral drugs to prevent HIV acquisition and transmission.},
  author={Jonathan Weber and Roger Tatoud and Sarah Fidler},
  journal={AIDS},
  year={2010},
  volume={24 Suppl 4},
  pages={S27-39}
}
This review considers the use of antiretroviral drugs specifically to prevent HIV transmission. Antiretroviral therapy (ART) can be implemented for the protection of uninfected individuals both before (preexposure prophylaxis) and after (postexposure prophylaxis) exposure to HIV infection. Preexposure prophylaxis may be used coitally dependently when individuals are intermittently exposed or by continuous daily dosing for those constantly exposed; postexposure prophylaxis is used in 28-day… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.
14 Citations
109 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 14 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 109 references

Decreases in community viral load are associated with a reduction in new HIV diagnoses in San Francisco [paper #33

  • M Das-Douglas, P Chu, +4 authors G. Colfax
  • In: 17th Conference on Retroviruses and…
  • 2010
Highly Influential
9 Excerpts

epidemic update 2009

  • AID UNAIDS.
  • Geneva, Switzerland: UNAIDS;
  • 2009
Highly Influential
4 Excerpts

Association of expanded HAART coverage with a decrease in new HIV diagnoses, particularly among injection drug users in British Columbia, Canada [paper #88LB

  • J Montaner, E Wood, T Kerr, B Yip, V Lima, K Shannon
  • In: 17th Conference on Retrovirus and…
  • 2010
Highly Influential
5 Excerpts

Antiretrovirals (ARV) for prevention: maraviroc (MVC) exposure in the semen (SE) and rectal tissue (RT) of healthy male volunteers after single and multiple dosing

  • K Brown, K Patterson, S Malone, N Shaleen, H Prince, J Dumond
  • In: 17th Conference on Retroviruses and…
  • 2010
1 Excerpt

Herpes simplex virus type 2 suppressive therapy with acyclovir or valacyclovir does not induce specific HIV-1 resistance in HSV-2/HIV-1 dually-infected persons [paper #91

  • J Baeten, J Lingappa, L Corey, A Wald, I Beck, L Frenkel
  • In: 17th Conference on Retrovirus and…
  • 2010

Similar Papers

Loading similar papers…